Searching News Database: Upjohn
HSMN NewsFeed - 15 Sep 2020
Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn
Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn
HSMN NewsFeed - 27 Mar 2019
Synspira Therapeutics Announces Appointment of Robert Gallotto as President and Chief Executive Officer
Synspira Therapeutics Announces Appointment of Robert Gallotto as President and Chief Executive Officer
HSMN NewsFeed - 2 Jan 2019
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
HSMN NewsFeed - 10 Nov 2017
Medivir Appoints Christina Herder as Executive Vice President Strategic Business Development
Medivir Appoints Christina Herder as Executive Vice President Strategic Business Development
HSMN NewsFeed - 3 Jun 2016
Getinge Group Appoints Jens Viebke as New President of Acute Care Therapies Business Category Unit
Getinge Group Appoints Jens Viebke as New President of Acute Care Therapies Business Category Unit
HSMN NewsFeed - 27 Oct 2015
CoLucid Pharmaceuticals Announces Election of Mark Corrigan, M.D., to Board of Directors
CoLucid Pharmaceuticals Announces Election of Mark Corrigan, M.D., to Board of Directors
HSMN NewsFeed - 8 May 2014
Timothy Maloney appointed President of Novartis Pharmaceuticals Canada Inc.
Timothy Maloney appointed President of Novartis Pharmaceuticals Canada Inc.
HSMN NewsFeed - 21 Oct 2013
Soligenix Announces Appointment of Marco Maria Brughera to its Board of Directors
Soligenix Announces Appointment of Marco Maria Brughera to its Board of Directors
HSMN NewsFeed - 19 Sep 2013
Neurotech Pharmaceuticals Adds Ophthalmic Leaders to Advance Groundbreaking Sight-Saving Therapies
Neurotech Pharmaceuticals Adds Ophthalmic Leaders to Advance Groundbreaking Sight-Saving Therapies
HSMN NewsFeed - 22 May 2013
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 7 Jan 2013
Celator(R) Pharmaceuticals Announces Appointment of Lisa DeLuca as Vice President, Regulatory Affairs
Celator(R) Pharmaceuticals Announces Appointment of Lisa DeLuca as Vice President, Regulatory Affairs
HSMN NewsFeed - 15 Nov 2012
Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
HSMN NewsFeed - 13 Sep 2012
Simcere Pharmaceutical Group Announces Appointment of New Chief Executive Officer
Simcere Pharmaceutical Group Announces Appointment of New Chief Executive Officer
HSMN NewsFeed - 7 Sep 2012
Mylan Announces Settlement Agreement in Litigation Relating to Detrol(R) LA
Mylan Announces Settlement Agreement in Litigation Relating to Detrol(R) LA
HSMN NewsFeed - 23 Apr 2012
Kolltan Pharmaceuticals Appoints Gerald McMahon, Ph.D., President & Chief Executive Officer
Kolltan Pharmaceuticals Appoints Gerald McMahon, Ph.D., President & Chief Executive Officer
HSMN NewsFeed - 8 Mar 2012
S1 Pharmaceuticals Announces New Executive Management and Scientific Advisory Board Appointments
S1 Pharmaceuticals Announces New Executive Management and Scientific Advisory Board Appointments
HSMN NewsFeed - 4 Oct 2011
NovaBay Pharmaceuticals Names David W. Stroman, Ph.D. as Head of Ophthalmic Drug Development
NovaBay Pharmaceuticals Names David W. Stroman, Ph.D. as Head of Ophthalmic Drug Development
HSMN NewsFeed - 18 Aug 2009
Kolltan Pharmaceuticals Expands Board of Directors and Senior Executive Team
Kolltan Pharmaceuticals Expands Board of Directors and Senior Executive Team
HSMN NewsFeed - 4 Jun 2009
Xanodyne Announces New President/CEO and Completes $38 Million Equity Financing
Xanodyne Announces New President/CEO and Completes $38 Million Equity Financing
HSMN NewsFeed - 13 May 2009
Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer
Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer
HSMN NewsFeed - 5 May 2009
CytRx Appoints Jaisim Shah Chief Business Officer and Senior Vice President of Business Development
CytRx Appoints Jaisim Shah Chief Business Officer and Senior Vice President of Business Development
HSMN NewsFeed - 3 Jul 2008
Mylan Announces Tentative FDA Approval for Generic Version of Antibiotic Zyvox(R) Tablets
Mylan Announces Tentative FDA Approval for Generic Version of Antibiotic Zyvox(R) Tablets
HSMN NewsFeed - 9 Jun 2008
EyeGate Pharma Adds Drug Development and Delivery Expert, Praveen Tyle, to Its Board of Directors
EyeGate Pharma Adds Drug Development and Delivery Expert, Praveen Tyle, to Its Board of Directors
HSMN NewsFeed - 14 May 2008
Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
HSMN NewsFeed - 7 Jan 2008
John R. Riesenberger Joins MannKind as Corporate Vice President and Chief Commercialization Officer
John R. Riesenberger Joins MannKind as Corporate Vice President and Chief Commercialization Officer
HSMN NewsFeed - 4 Jan 2008
Follica Raises $5.5 M To Advance New Treatment for Androgenetic Alopecia Into the Clinic
Follica Raises $5.5 M To Advance New Treatment for Androgenetic Alopecia Into the Clinic
HSMN NewsFeed - 19 Dec 2007
Curis, Inc. Announces Appointment of Stephen K. Carter, M.D. to its Board of Directors
Curis, Inc. Announces Appointment of Stephen K. Carter, M.D. to its Board of Directors
HSMN NewsFeed - 29 May 2007
IMPAX Receives Final FDA Approval for Generic Xanax(R) XR Extended Release Tablets
IMPAX Receives Final FDA Approval for Generic Xanax(R) XR Extended Release Tablets
HSMN NewsFeed - 7 May 2007
Bill Cadwallader Joins Velcura Therapeutics, Inc. as Executive Vice President of Corporate Development
Bill Cadwallader Joins Velcura Therapeutics, Inc. as Executive Vice President of Corporate Development
HSMN NewsFeed - 23 Apr 2007
DiObex Announces the Appointment of David Cory as Chief Executive Officer
DiObex Announces the Appointment of David Cory as Chief Executive Officer
HSMN NewsFeed - 17 Apr 2007
Erimos Pharmaceuticals Names Dr. Scott Mohrland as President and Chief Executive Officer
Erimos Pharmaceuticals Names Dr. Scott Mohrland as President and Chief Executive Officer
HSMN NewsFeed - 22 Jan 2007
Isis Announces Appointment of Jeffrey M. Jonas, M.D. as Executive Vice President
Isis Announces Appointment of Jeffrey M. Jonas, M.D. as Executive Vice President
HSMN NewsFeed - 21 Nov 2006
Altus Pharmaceuticals Appoints Shire Executive David Pendergast to Board of Directors
Altus Pharmaceuticals Appoints Shire Executive David Pendergast to Board of Directors
HSMN NewsFeed - 26 Sep 2006
ProNAi Announces Executive Team Buildup, Names New CEO and Top Development Management
ProNAi Announces Executive Team Buildup, Names New CEO and Top Development Management
HSMN NewsFeed - 17 Jul 2006
Michael Tansey, M.D. Joins La Jolla Pharmaceutical Company as Chief Medical Officer
Michael Tansey, M.D. Joins La Jolla Pharmaceutical Company as Chief Medical Officer
Additional items found! 58
Members Archive contains
58 additional stories matching:
Upjohn
(Password required)
Upjohn
(Password required)
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!